Poster
Session I |
13:00-14:40
k100l |
Session
X |
14:40-15:10
k30l |
|
Chair:
Yasuo Ariumi |
|
O-2-12 |
Hirokazu
Tamamura
Tokyo Medical and Dental University, Japan
|
Cell-permeable
stapled peptides with integrase inhibitory activity derived from HIV
gene products |
Session
XI |
15:10-15:40
k30l |
|
Chair:
Yosuke Maeda |
|
O-2-13 |
Shinya
Suzu
Kumamoto University, Japan |
Fibroblastic
leukocytes as a unique type of HIV-1 target cells |
Session
XII |
15:40-16:55
k75l |
|
Chair:
Takamasa Ueno |
|
O-2-14 |
Hiroyuki
Gatanaga
NCGM / Kumamoto University, Japan |
Prevalence and
effects of rilpivirine resistance-associated mutations |
|
O-2-15 |
Zabrina
L. Brumme
Simon Fraser University, Canada |
HIV adaptation
to HLA: the power of the comparative approach |
Session
X |
16:55-17:25
k30l |
|
Chair:
Shuzo Matsushita |
|
O-2-16 |
Yasuo
Ariumi
Kumamoto University, Japan |
HIV-1 Vpr and
p21Waf1/Cip1 restrict the LINE-1 retrotransposition |
Session
X |
17:25-17:55
k30l |
|
Chair:
Seiji Okada |
|
O-2-17 |
Takeo
Kuwata
Kumamoto University, Japan |
Acquisition of
resistance to the CCR5 antagonist cenicriviroc renders HIV-1 sensitive
to neutralizing antibodies |
19:00-21:00
k120l |
Reception |